Opinion: Theranos verdict won’t stop next big fraud


Holmes’ case raises the important question of whether the testimony and result will serve as object lessons for investors confronted with cheery promises in the future. Bet your money that the answer is ‘no’. — AFP

Elizabeth Holmes, the founder and CEO of the medical device company Theranos, was convicted Jan 3 on multiple counts of defrauding investors following a four-month trial in federal court in San Jose.

Theranos, which rode a tide of positive publicity in 2013 and 2014 after introducing what it claimed was novel technology for making blood testing simpler, cheaper and more efficient, shut down in 2018 after investigations established that the claims were false. Holmes and her second-in-command, Ramesh “Sunny” Balwani, were indicted on 12 counts of fraud in 2020 one count was later dropped. Balwani’s trial is scheduled for this year.

Subscribe now and receive FREE sooka plan for 1 month.
T&C applies.

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
   

Next In Tech News

Nvidia surpasses $3.6 trillion market value after Trump win
Pinterest's revenue forecast disappoints investors looking for holiday season ad boost
US Cellular to sell some spectrum licenses to AT&T for $1 billion
Datadog raises annual forecast betting on AI-driven cybersecurity demand
Italy minister open to reviewing tax hike on cryptocurrencies
Dutch chipmaker NXP sees sales growth averaging 6-10% -CEO
Italy to change web tax in bid to overcome US objections
JAL-Sumitomo JV secures right to place order for up to 100 Archer air-taxis
Software provider EPAM lifts annual forecasts as IT spending rises
India raids offices of sellers using Amazon, Flipkart platforms, sources say

Others Also Read